Supplemental Materials for JAAD Publication JAAD-D-21-01712R3, Phase 2 Randomized, Dose-Ranging Trial of CTP-543, a Selective Janus Kinase Inhibitor, in Moderate to Severe Alopecia Areata

Published: 23 March 2022| Version 1 | DOI: 10.17632/jgpsf32f86.1
Contributors:
,
Natasha Atanaskova Mesinkovska,
Paradi Mirmirani,
Suzanne Bruce,
Steve Kempers,
Emma Guttman-Yassky,
Janet Roberts,
Amy McMichael,
Maria Colavincenzo,
Colleen Hamilton,
Ginny Braman,
Jim Cassella

Description

These are supplemental data sets to the JAAD publication entitled "Phase 2 Randomized, Dose-Ranging Trial of CTP-543, a Selective Janus Kinase Inhibitor, in Moderate to Severe Alopecia Areata". Supplemental figures include: Figure S1: Enrollment and Patient Disposition; Figure S2: Patient SALT Improvement Thresholds; Figure S3: Percentage of Patients Achieving SALT score ≤20 Over Treatment Period; Figure S4. Patient-Reported Outcomes.

Files

Categories

Hair Disorder, Management of Hair Loss Symptom, Alopecia Areata, Janus Kinase

License